Related Experiment Video
Updated: Jul 5, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Routine hematologic clinical tests as prognostic markers in patients with acute coronary syndromes
Samuel J Turner1, Terry R Ketch, Sanjay K Gandhi
1Department of Internal Medicine/Cardiology, Wake Forest University Health Sciences, Winston-Salem, NC 27157-1045, USA.
Insights
Routine blood tests can predict outcomes for acute coronary syndrome (ACS) patients. Elevated white blood cells, anemia, and high platelet counts indicate higher risks for mortality and adverse events in ACS.
Area of Science:
- Cardiology
- Hematology
- Clinical Medicine
Background:
- Identifying high-risk patients with acute coronary syndrome (ACS) is crucial for effective treatment.
- Routine hematologic tests, part of a complete blood count, offer valuable prognostic information.
- Existing research highlights associations between specific blood cell counts and adverse outcomes in ACS.
Purpose of the Study:
- To review the literature on the prognostic utility of routine hematologic tests in ACS patients.
- To explore the associations between white blood cell count, hemoglobin/hematocrit, and platelet count with clinical outcomes.
- To discuss potential biological mechanisms underlying these hematologic associations in ACS.
Main Methods:
- Systematic review of existing literature.
- Analysis of studies correlating complete blood count parameters with ACS prognosis.
- Synthesis of data on white blood cell count, hemoglobin, hematocrit, and platelet count.
Main Results:
- Elevated white blood cell counts in ACS correlate with increased risk of mortality, heart failure, shock, and left ventricular dysfunction.
- Anemia (low hemoglobin/hematocrit) is linked to a higher risk of mortality in ACS.
- Elevated platelet counts are associated with poorer clinical and angiographic outcomes in ACS patients.
Conclusions:
- Complete blood count parameters serve as accessible and valuable prognostic markers in acute coronary syndrome.
- Hematologic indices like white blood cell count, hemoglobin, and platelet count can aid in risk stratification for ACS.
- Further research into the mechanistic links between these hematologic markers and ACS pathophysiology is warranted.
Abstract:
Prognostic markers are needed to identify patients with acute coronary syndrome (ACS) who are at high risk for adverse events. Although the search for new biomarkers is quite active, prognostic information is available from routine hematologic tests, such as the complete blood count. For example, elevated white blood cell counts during ACS are associated with increased risk of mortality, heart failure, shock, and left ventricular dysfunction. Anemia is associated with increased risk of mortality, whereas elevated platelet counts predict poorer clinical and angiographic outcomes. In this review, we summarize the literature regarding the use of clinical hematology tests including white blood cell count, hemoglobin and hematocrit values, and platelet count as prognostic markers in patients with ACS, and we describe potential mechanisms to explain these associations.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Dysrhythmias V: Evaluating Dysrhythmias
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies